## Distinguishing Nasopharyngeal Angiofibroma from Nasopharyngeal Carcinoma ### Key Demographic and Clinical Discriminators **Key Point:** Nasopharyngeal angiofibroma (NAF) occurs almost exclusively in adolescent and young adult males (peak 14–25 years), whereas nasopharyngeal carcinoma (NPC) typically presents in middle-aged to older adults with no strong male predominance in endemic regions. ### Comparative Table | Feature | Nasopharyngeal Angiofibroma | Nasopharyngeal Carcinoma | | --- | --- | --- | | **Age of onset** | Adolescence (14–25 years) | Middle-aged to elderly (40–60 years) | | **Gender** | Almost exclusively male | Male > Female (2–3:1), but affects both | | **Lymphadenopathy** | Absent (benign, no nodal spread) | Present in 70–80% at diagnosis | | **Bone erosion** | Slow, expansile remodeling | Rapid, infiltrative destruction | | **Risk factors** | None identified | EBV, tobacco, alcohol, genetic | | **Histology** | Benign vascular proliferation | Malignant epithelial (SCC, undifferentiated) | ### Clinical Pearl **High-Yield:** The age and sex profile is the single most reliable discriminator at first presentation. A teenage boy with epistaxis and nasopharyngeal mass should raise suspicion for NAF; a 50-year-old with the same presentation and cervical nodes points to NPC. ### Why This Matters **Clinical Pearl:** NAF is a benign, locally aggressive vascular tumor with no malignant potential and no lymph node involvement. NPC is a squamous cell carcinoma with early nodal metastasis and systemic spread potential. The demographic profile guides imaging urgency, staging, and treatment intent (curative surgery vs. chemoradiation). [cite:Park 26e Ch 15] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.